Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Neurosurgery Customer from Germany Orders Nexstim NBS System 5
Press release, Helsinki, 26 April 2024 at 3 PM (EEST) Neurosurgery Customer from Germany Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for a new NBS System 5 from an existing customer hospital in Germany. The system will be used in neurosurgery.The Nexstim Navigated Brain Stimulation (NBS) System 5 is indicated for non-invasive mapping of the primary motor cortex of the brain to its cortical gyrus and localization of...
Nasdaq GlobeNewswire
26/04/2024
Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive…
The Annual General Meeting approved the financial statements for the financial year 1 January–31 December 2023 and resolved to discharge the members of the Board of Directors and the CEO from liability for the financial period 1 January–31 December 2023. The Annual General Meeting approved the financial statements for the financial year 1 January–31 December 2023 and resolved to discharge the members of the Board of Directors and the CEO from liability for the financial period 1 January–31…
PR Newswire
26/04/2024
Novo Nordisk A/S – Total number of voting rights and share capital in Novo…
Bagsværd, Denmark, 26 April 2024– In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred. Referring to Company Announcement no 32/2024 dated 24 April 2024, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 26 April 2024...
Nasdaq GlobeNewswire
26/04/2024
Hisense Unveils the Revolutionary 7S Smart Laundry Washer & Dryer, Redefining…
Hisense is committed to developing smart and reliable appliances that meet the ever-evolving needs of consumers regionally. The 7S Smart Laundry Washer & Dryer embodies this commitment, providing a seamless blend of advanced technology, superior quality, and sustainable practices. Hisense is committed to developing smart and reliable appliances that meet the ever-evolving needs of consumers regionally. The 7S Smart Laundry Washer & Dryer embodies this commitment, providing a seamless…
PR Newswire
26/04/2024
PATCHOULI BECOMES THE NEXT ADDITION TO SCENTAIR®'S UK HOME FRAGRANCE OFFERINGS
Its newest addition to the curated library is a twist on an all-time favorite, Patchouli. With its bohemian and free-spirited roots dating back to the 1960s, Patchouli has recently experienced a resurgence in popularity with younger generations. ScentAir's Whisper HOME Patchouli fragrance combines the essence of tradition with modern notes to create a warm and inviting atmosphere for any home. Its newest addition to the curated library is a twist on an all-time favorite, Patchouli. With its...
PR Newswire
26/04/2024
Sobi establishes MTN programme with a framework amount of SEK 10 billion…
SEB has been appointed arranger of the MTN Programme and will also act as dealer together with Danske Bank, Nordea and Svenska Handelsbanken. Mannheimer Swartling acted as legal adviser to Sobi. SEB has been appointed arranger of the MTN Programme and will also act as dealer together with Danske Bank, Nordea and Svenska Handelsbanken. Mannheimer Swartling acted as legal adviser to Sobi. Sobi Sobi® is a specialised international biopharmaceutical company transforming the lives of people...
PR Newswire
26/04/2024
Composition of the Nomination Committee of Orion Corporation
ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 26 APRIL 2024 at 11.15 EEST Composition of the Nomination Committee of Orion Corporation The Board of Directors of Orion Corporation has appointed the following persons to the Nomination Committee of the company: Annika EkmanPetteri KarttunenMinna MaasiltaVeli-Matti MattilaHilpi RautelinSeppo Salonen Hilpi Rautelin was appointed as Chair of the...
Nasdaq GlobeNewswire
26/04/2024
OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood…
Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress. Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities. A study found that high blood pressure is estimated to cause more than 10 million deaths worldwide every year. Another research in Japan shows that 40% of hypertension patients are unaware of their symptoms or leave them…
PR Newswire
26/04/2024
SK chemicals Wraps Up ChinaPlas Triumphantly and Unveils Blueprint for Circular…
SHANGHAI and SEONGNAM, South Korea, April 26, 2024 /PRNewswire/ -- The complete resource circulation system (Closed Loop) presented by SK chemicals at the international exhibition has garnered praise from industry officials and clients. SHANGHAI and SEONGNAM, South Korea,April 26, 2024/PRNewswire/ -- The complete resource circulation system (Closed Loop) presented by SK chemicals at the international exhibition has garnered praise from industry officials and clients. SK chemicals...
PR Newswire
26/04/2024
ZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27…
RIGHT TO PARTICIPATE IN THE COMPANY MEETING RIGHT TO PARTICIPATE IN THE COMPANY MEETING Shareholders wishing to attend the annual general meeting must: i. be entered in the shareholder register maintained by Euroclear Sweden AB byFriday, May 17, 2024, and ii. have notified their intention to attend the meeting byFriday, May 24, 2024, as per the instructions below. Shareholders who have their shares nominee-registered must temporarily register the shares in...
PR Newswire
26/04/2024
Implantica publishes Annual Report 2023
For further information, please contact: For further information, please contact: Nicole Pehrsson, Chief Corporate Affairs Officer Telephone (CH): +41 (0)79 335 09
[email protected]
Implantica is listed on Nasdaq First North Premier Growth Market inStockholm. The company's Certified Adviser is FNCA Sweden AB,
[email protected]
The information was sent for publication, through the agency of the contact person set out above, onApril 26, 2024, at08:30 a.m...
PR Newswire
26/04/2024
Electrolux Group Interim report Q1 2024
President and CEO Jonas Samuelson's comment President and CEOJonas Samuelson'scomment "After having had the privilege to serve more than eight years as President & CEO of Electrolux Group, I have decided to leave my position onJanuary 1, 2025. This is a good time to hand over to a successor who can put all energy into leading this great company into the next phase during the coming years. We have set a clear strategic direction with focus on the mid- and premium segments through...
PR Newswire
26/04/2024
PCI Biotech Holding ASA - Annual Report 2023
The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2023 is also available on the company's website www.pcibiotech.com.For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CEO,
[email protected]
, Mobile: +47 940 05 757This...
Nasdaq GlobeNewswire
26/04/2024
Interim report January-March 2024: Medicover
Definition and reconciliation of alternative performance measures are available at www.medicover.com/financial-information.1) LTM: last twelve months (1 April 2023-31 March 2024) Definition and reconciliation of alternative performance measures are available at www.medicover.com/financial-information.1) LTM: last twelve months (1 April 2023-31 March 2024) CEO Statement I am pleased to be able to report a strong start to the year with good demand levels across the businesses as well...
PR Newswire
26/04/2024
ELFBAR and LOST MARY unveil progress in combatting illicit vapes
ELFBAR and LOST MARY reveal their efforts to contain the spread of illicit vapes, which encompass measures including, but not limited to, proactively working with regulators worldwide, advocating for robust enforcement, bringing trademark infringement to court, shutting down counterfeit manufacturers, scanning and spotting fake products in retail channels, engaging retail groups, and launching public awareness campaigns. ELFBAR and LOST MARY reveal their efforts to contain the spread of…
PR Newswire
26/04/2024
Nexstim Plc Business Update Q1 2024
Press release, Helsinki, 26 April 2024 at 9 AM (EEST) Nexstim Plc Business Update Q1 2024 Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) announces the key highlights of the Company's business operations during Q1 2024. CEO Mikko Karvinen's Business Update In line with our main strategic objective, we have continued to focus on profitable net sales growth. The sales of new systems at the beginning of this year has been slow, which is typical considering that hospitals' budgets...
Nasdaq GlobeNewswire
26/04/2024
SKF First-quarter report 2024: A more resilient and competitive SKF
"Our first quarter performance marked another step towards a more resilient and competitive SKF. In soft market conditions, we delivered a strong adjusted operating margin of 13.4%, somewhat ahead of Q1 2023. The margin improvement clearly demonstrates our improved resilience in a situation where organic growth shifted from +10% in Q1 last year to -7% this year. "Our first quarter performance marked another step towards a more resilient and competitive SKF. In soft market…
PR Newswire
26/04/2024
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of…
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products.A CHMP positive opinion is one of the final steps before marketing authorization can be granted by the European Commission – a final decision is...
Nasdaq GlobeNewswire
26/04/2024
Anti-Adhesion Products Market Projected to Reach $1.69 billion by 2030 -…
Anti-adhesion products play a crucial role in modern surgeries by preventing abnormal scar tissue formation between tissues and organs, thus minimizing complications and enhancing recovery. As surgical numbers rise globally, especially in gynecology, abdominal, and cardiovascular areas, the usage of these products is becoming increasingly essential. Challenges include unclear standardization due to varying surgical techniques and the limited efficacy in some cases. Ongoing research and…
PR Newswire
26/04/2024
Contract Research Organization Services Market Projected to Reach $184.21…
The landscape of clinical research services is witnessing a dynamic shift, offering crucial support to the sectors of pharmaceuticals, biotechnology, and medical device industries in their aim to navigate the complicated journey of drug development and market introduction worldwide. These contract research organizations (CROs) are the backbone of medical innovation, providing specialized services, including regulatory submissions, clinical trial management, data analysis, and comprehensive…
PR Newswire
26/04/2024
Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of…
Key Takeaways from the Urine Output Monitoring Systems Market Report Key Takeaways from the Urine Output Monitoring Systems Market Report To read more about the latest highlights related to the urine output monitoring systems market, get a snapshot of the key highlights entailed in theGlobal Urine Output Monitoring Systems Market Report Urine Output Monitoring Systems Overview Urine output monitoring systems play a crucial role in healthcare settings, offering real-time...
PR Newswire
25/04/2024
Combined General Meeting of May 16, 2024
Combined General Meeting of May 16, 2024Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “ Company ”), will hold its Combined General Meeting (the “ General Meeting ”) on May 16, 2024, at 10:00 a...
Nasdaq GlobeNewswire
25/04/2024
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year…
Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT),a late-stage biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases, today announced the publication of its 2024 Extra-Financial Performance Report (fiscal year 2023). Third edition of the Extra-Financial Performance report Since 2022, GENFIT has published a detailed Extra-Financial Performance report in...
Nasdaq GlobeNewswire
25/04/2024
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar…
CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA ®CAMBRIDGE, Mass., April25, 2024(GLOBE NEWSWIRE) --BiogenInc. (Nasdaq: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for TOFIDENCE™ (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA ®1. The intravenous...
Nasdaq GlobeNewswire
25/04/2024
Altri Comunicati